Cancer Progress 2015

Tuesday, March 17, 2015
7:00 – 8:00am Registration and Continental Breakfast
8:00 – 8:15am Opening Remarks
Audio file: 
8:15 – 9:15am Plenary Keynote: Progress, at What Price?
Moderator: Ed Saltzman, President, Defined Health
Audio file:
Panelists:

  • Peter Bach, MD, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
  • Michael Kolodziej, MD, National Medical Director, Oncology Solutions, Aetna
  • Lee Newcomer, MD, MHA, SVP, Oncology, Genetics and Women’s Health, United Healthcare
  • Leonard Saltz, MD, Professor of Medicine, Weill Cornell Medical College; Chief, Gastrointestinal Oncology Service, Chair, Pharmacy and Therapeutics Committee, Memorial Sloan Kettering Cancer Center
9:15 – 10:30am A Day in the Life of a Breast Cancer Doctor: Integrating Omics to Optimize Patient Outcomes
Moderator: Otis Webb Brawley, MD, FACP, Chief Medical and Scientific Officer, Executive Vice President, Research, American Cancer Society
Audio file:
Panelists:

10:30 – 10:45am Networking Break
10:45 – 12:00pm Tumor Panel I: Rare and Pediatric Cancers
Moderator: Mike Rice, MS, MBA, Senior Consultant, Defined Health
Audio file:
Panelists:

  • Peter C. Adamson, MD, Chair, Children’s Oncology Group, Alan R. Cohen Endowed Chair in Pediatrics, The Children’s Hospital of Philadelphia
  • Meredith K. Chuk, MD, Scientific Liaison for Sarcoma, Medical Officer, FDA
  • Carlos Rodriguez-Galindo, MD, Associate Professor, Department of Pediatrics, Harvard Medical School; Medical Director, Pediatric Oncology Clinical Trials, Pediatric Oncology, Dana-Farber Cancer Institute; Director, Solid Tumor Program, Pediatric Oncology, Dana-Farber Cancer Institute
  • Peter Sandor, MD, MBA, Vice President, Global Marketing Oncology, Amgen
  • Maoxia Zheng, PhD, Global Development Team Leader, Pediatric Oncology, Genentech
12:00 – 1:15pm Networking Luncheon
1:15 – 2:30pm Immunotherapy I: Targeting Checkpoint, Co-Stimulatory and Novel Immunomodulatory MOAs
Moderator: Jeff Bockman, PhD, VP, Defined Health
Audio file:
Panelists:

  • Ada Braun, MD, PhD, Chief Medical Officer, Biothera
  • Axel Hoos, MD, PhD, VP, Oncology Research and Development, GlaxoSmithKline
  • Johanna Joyce, PhD, Member, Memorial Sloan Kettering Cancer Center
  • Hy Levitsky, MD, Adjunct Professor, Oncology, Medicine and Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
  • Nils Lonberg, PhD, SVP, Biologics Discovery, Bristol-Myers Squibb
  • Harlan Robins, PhD, Co-Founder and Chief Scientific Officer, Adaptive Biotechnologies
  • Jedd Wolchok, MD, PhD, Ludwig Center at Memorial Sloan Kettering Cancer Center
2:30 – 3:45pm Immunotherapy II: Engineered Cell Therapy
Moderator: Mike Rice, MS, MBA, Senior Consultant, Defined Health
Audio file:
Panelists:

  • Renier J. Brentjens, MD, PhD, Director, Cellular Therapeutics, Associate Attending Physician, Dept of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center
  • Thomas J. Farrell, CEO, Bellicum Pharmaceuticals
  • Dolores J. Schendel, PhD, Chief Scientific Officer, Medigene
  • Gaurav Shah, MD, Global Clinical Program Head (CART / CTL019 Adoptive T-cell Therapies)Novartis Pharmaceuticals
3:45 – 4:00pm Networking Break
4:00 – 5:15pm Tumor Panel II: B-Cell Malignancies: Recent Advances, Remaining Challenges and Promising New Approaches
Moderator: Mike Rice, MS, MBA, Senior Consultant, Defined Health
Audio file:
Panelists:

  • Omar Abdel-Wahab, MD, Hematologist/Oncologist, Memorial Sloan Kettering Cancer Center
  • Stanley R. Frankel, MD, Adjunct Associate Professor of Medicine, Division of Hematology/Oncology, Columbia University College of Physicians and Surgeons
  • William Grossman, MD, PhD, Therapeutic Area Lead, Oncology-Global Pharmaceutical R&D/Global Medical Affairs, AbbVie
  • Thomas J. Kipps, MD, PhD, Evelyn and Edwin Tasch Chair in Cancer Research, Distinguished Professor & Deputy Director, Research Operations, UC San Diego Moores Cancer Center
5:15 – 6:30pm Combination Therapies: Challenges and Opportunities
Moderator: Jeff Bockman, PhD, VP, Defined Health
Audio file:
Panelists:

  • Richard Brian Gaynor, MD, VP, Product Development/Medical Affairs, Eli Lilly and Company
  • Ivan Horak, MD, Chief Scientific/Medical Officer, Symphogen A/S
  • Noemi Rosa, Novartis
  • Eric Rowinsky, MD, Chief Medical Officer, Head of Research & Development, Stemline Therapeutics
6:30 – 8:30pm Cancer Progress 2015 Reception
Wednesday, March 18, 2015
7:00 – 8:00am Continental Breakfast
8:00 – 8:15am Opening Remarks
Audio file:
8:15 – 9:15am Keynote Address: Technology and Big Data: Transforming Cancer Research and Care
Audio file:
9:15 – 10:30am Bucket Trials and Drug Umbrellas
Moderator: Haleh Saber, PhD, Principal Consultant, PAREXEL International
Audio file:
Panelists:

10:30 – 10:45am Networking Break
10:45 – 12:00pm Moving Beyond Mutations to Key Drivers: From Sequence to Function to Decision
Moderator: Jeremy P. Goldberg, President, JPG Healthcare LLC
Audio file:
Panelists:

12:00 – 1:15pm Networking Luncheon
1:15 – 2:30pm Exceptional Responders
Moderator: David Solit, MD, Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Audio file:
Panelists:

2:30 – 3:45pm Funding and Conducting Cancer Research: New Paths Forward
Moderator: Mark J. Simon, Advisor, Torreya Partners LLC
Audio file:
Panelists:

  • Thomas O. Daniel, MD, Executive Vice President & President, Global Research and Early Development, Global Research, Celgene
  • Louis J. DeGennaro, PhD, President & CEO, Leukemia & Lymphoma Society
  • Kathleen A. Denis, PhD, CLP, AVP, Office of Technology Transfer, The Rockefeller University
  • Louise M. Perkins, PhD, Chief Science Officer, Melanoma Research Alliance
  • Nathan P. Sanburn, Director, Strategy and Business Development Oncology, Eli Lilly and Company
3:45 – 4:00pm Networking Break
4:00 – 5:15pm Evolution of Cancer: New Ways of Thinking about an Old Scourge
Moderator: Jean-Pierre Bizzari, MD, EVP, Clinical Research & Development, Celgene
Audio file:
Panelists:

5:15pm Closing Remarks
5:30pm Cancer Progress 2015 Conference Concludes